Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Phase III Trial of Maintenance Gefitinib or Placebo After Concurrent Chemoradiotherapy and Docetaxel Consolidation in Inoperable Stage III Non–Small-Cell Lung Cancer: SWOG S0023
2008
Meta-Analysis of Concomitant Versus Sequential Radiochemotherapy in Locally Advanced Non–Small-Cell Lung Cancer
2010 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Catalytic Asymmetric Three‐Component Synthesis of Homoallylic Amines
2013 StandoutNobel
Paclitaxel in Advanced Non-Small Cell Lung Cancer
2000
EGFR Antagonists in Cancer Treatment
2008 Standout
Pancreatic cancer
2004 Standout
Targeting hypoxia in cancer therapy
2011 Standout
A proteomic atlas of senescence-associated secretomes for aging biomarker development
2020 Standout
Chemoradiation for upper aerodigestive tract cancer: balancing evidence from clinical trials with individual patient recommendations
2003
The management of respiratory motion in radiation oncology report of AAPM Task Group 76a)
2006 Standout
A painful peripheral neuropathy in the rat produced by the chemotherapeutic drug, paclitaxel
2001 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Ongoing Care of Patients After Primary Treatment for Their Cancer
2003
Results of a Survey of Neurosurgical Practice Patterns Regarding the Prophylactic use of Anti-Epilepsy Drugs in Patients with Brain Tumors
2005
Metastatic non-small-cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2016 Standout
Dose-escalating conformal thoracic radiation therapy with induction and concurrent carboplatin/paclitaxel in unresectable stage IIIA/B nonsmall cell lung carcinoma
2001
Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
1996 Standout
Pelvic Radiation with Concurrent Chemotherapy Compared with Pelvic and Para-Aortic Radiation for High-Risk Cervical Cancer
1999 Standout
Glioblastoma and Other Malignant Gliomas
2013 Standout
Report From the International Atomic Energy Agency (IAEA) Consultants' Meeting on Elective Nodal Irradiation in Lung Cancer: Non–Small-Cell Lung Cancer (NSCLC)
2008
Cancer Statistics, 2006
2006 Standout
Radiotherapy plus Cetuximab for Squamous-Cell Carcinoma of the Head and Neck
2006 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Induction Chemotherapy with Carboplatin, Irinotecan, and Paclitaxel Followed by High Dose Three-Dimension Conformal Thoracic Radiotherapy (74 Gy) with Concurrent Carboplatin, Paclitaxel, and Gefitinib in Unresectable Stage IIIA and Stage IIIB Non-small Cell Lung Cancer
2008
Paclitaxel (Taxol)
1995 Standout
Anthracyclines: Molecular Advances and Pharmacologic Developments in Antitumor Activity and Cardiotoxicity
2004 Standout
Targeting oxidative stress in disease: promise and limitations of antioxidant therapy
2021 Standout
A prospective phase II trial of EGCG in treatment of acute radiation-induced esophagitis for stage III lung cancer
2015
Local Surgical, Ablative, and Radiation Treatment of Metastases
2009
Radiation-Induced Lung Injury (RILI)
2019
Weekly docetaxel in the treatment of elderly patients with advanced nonsmall cell lung carcinoma
2000
Bevacizumab plus Radiotherapy–Temozolomide for Newly Diagnosed Glioblastoma
2014 Standout
Lung cancer: current therapies and new targeted treatments
2016 Standout
Preoperative Chemoradiation for Patients With Locally Advanced Adenocarcinoma of the Pancreas
1999
Docetaxel plus Prednisone or Mitoxantrone plus Prednisone for Advanced Prostate Cancer
2004 Standout
Recent advances with liposomes as pharmaceutical carriers
2005 Standout
Recent advances in MMP inhibitor design
2006
Predicting distant failure in early stage NSCLC treated with SBRT using clinical parameters
2016
Early and locally advanced non-small-cell lung cancer (NSCLC): ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2017 Standout
Cetuximab in advanced non-small cell lung cancer
2006
Response to chemotherapy, quality of life benefits and survival in advanced non-small cell lung cancer: review of literature results
2001
Phase 3 Trials of Stereotactic Radiosurgery With or Without Whole-Brain Radiation Therapy for 1 to 4 Brain Metastases: Individual Patient Data Meta-Analysis
2015
Combined modality radioimmunotherapy
2002
Medical management of patients with brain tumors
2006
Why avoid the hippocampus? A comprehensive review
2010
Comparison of antiangiogenic activities using paclitaxel (taxol) and docetaxel (taxotere)
2003
Malignant Gliomas in Adults
2008 Standout
Patterns of Disease Recurrence after SABR for Early Stage Non–Small-Cell Lung Cancer: Optimizing Follow-Up Schedules for Salvage Therapy
2015
Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.
1995
Disease progression or pseudoprogression after concomitant radiochemotherapy treatment: Pitfalls in neurooncology
2008
A Simple Enantioconvergent and Chemoenzymatic Synthesis of Optically Active α‐Substituted Amides
2011 StandoutNobel
Phase I and pharmacologic study of paclitaxel administered weekly in patients with relapsed ovarian cancer.
1997
Primary brain tumours in adults
2012 Standout
A systematic review shows no performance benefit of machine learning over logistic regression for clinical prediction models
2019 Standout
Primary Analysis of a Phase II Randomized Trial Radiation Therapy Oncology Group (RTOG) 0212: Impact of Different Total Doses and Schedules of Prophylactic Cranial Irradiation on Chronic Neurotoxicity and Quality of Life for Patients With Limited-Disease Small-Cell Lung Cancer
2010
Phase II trial of single-agent weekly docetaxel in hormone-refractory, symptomatic, metastatic carcinoma of the prostate
2001
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Comparison of Four Chemotherapy Regimens for Advanced Non–Small-Cell Lung Cancer
2002 Standout
Metastatic non-small cell lung cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
2018 Standout
Optimizing chemoradiation therapy approaches to unresectable stage III non–small cell lung cancer
2001
Neurocognition in patients with brain metastases treated with radiosurgery or radiosurgery plus whole-brain irradiation: a randomised controlled trial
2009 Standout
Basic characterization of 64Cu-ATSM as a radiotherapy agent
2005
Comparison of particle beam therapy and stereotactic body radiotherapy for early stage non-small cell lung cancer: A systematic review and hypothesis-generating meta-analysis
2017
Literature-based recommendations for treatment planning and execution in high-dose radiotherapy for lung cancer
2004
Poly (amino acid) micelle nanocarriers in preclinical and clinical studies
2008
A Perivascular Niche for Brain Tumor Stem Cells
2007 Standout
Cancer of the Ovary
2004 Standout
Potential for reduced toxicity and dose escalation in the treatment of inoperable non–small-cell lung cancer: A comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation
2003
Phase I Trial of Taxol as a Radiation Sensitizer with Cisplatin in Advanced Cervical Cancer
1997
Riding the Crest of the Teachable Moment: Promoting Long-Term Health After the Diagnosis of Cancer
2005 Standout
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Phase I Study of Paclitaxel in Combination With a Multidrug Resistance Modulator, PSC 833 (Valspodar), in Refractory Malignancies
2000
Induction Chemotherapy Followed by Chemoradiotherapy Compared With Chemoradiotherapy Alone for Regionally Advanced Unresectable Stage III Non–Small-Cell Lung Cancer: Cancer and Leukemia Group B
2007
Coordinating Radiometals of Copper, Gallium, Indium, Yttrium, and Zirconium for PET and SPECT Imaging of Disease
2010 Standout
Preoperative Paclitaxel and Concurrent Rapid-Fractionation Radiation for Resectable Pancreatic Adenocarcinoma: Toxicities, Histologic Response Rates, and Event-Free Outcome
2002
Randomized Double-Blind Trial of Combined Modality Treatment With or Without Amifostine in Unresectable Stage III Non–Small-Cell Lung Cancer
2003
Phase I clinical trial of weekly combined paclitaxel plus docetaxel in patients with solid tumors
2000
Randomized Phase III Trial of Sequential Chemoradiotherapy Compared With Concurrent Chemoradiotherapy in Locally Advanced Non–Small-Cell Lung Cancer: Groupe Lyon-Saint-Etienne d'Oncologie Thoracique–Groupe Français de Pneumo-Cancérologie NPC 95-01 Study
2005
Degradable Controlled-Release Polymers and Polymeric Nanoparticles: Mechanisms of Controlling Drug Release
2016 Standout
Matrix Metalloproteinases As Novel Biomarker s and Potential Therapeutic Targets in Human Cancer
2009
Phase III Study of Cisplatin, Etoposide, and Concurrent Chest Radiation With or Without Consolidation Docetaxel in Patients With Inoperable Stage III Non–Small-Cell Lung Cancer: The Hoosier Oncology Group and U.S. Oncology
2008
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
2014 Standout
Management of brain metastases
2016
Phase III Trial of Prophylactic Cranial Irradiation Compared With Observation in Patients With Locally Advanced Non–Small-Cell Lung Cancer: Neurocognitive and Quality-of-Life Analysis
2010
A Phase I and Pharmacokinetic Study of Paclitaxel Poliglumex (XYOTAX), Investigating Both 3-Weekly and 2-Weekly Schedules
2005
Multistage nanoparticle delivery system for deep penetration into tumor tissue
2011 StandoutNobel
Radiosensitization With Carboplatin for Patients With Unresectable Stage III Non–Small-Cell Lung Cancer: A Phase III Trial of the Cancer and Leukemia Group B and the Eastern Cooperative Oncology Group
1999
Structural Investigations into the Stereochemistry and Activity of a Phenylalanine-2,3-aminomutase from Taxus chinensis
2014 StandoutNobel
Reactive Oxygen Species (ROS)-Based Nanomedicine
2019 Standout
Preclinical studies with Erlotinib (Tarceva)
2003
Guidelines for the Management of Aneurysmal Subarachnoid Hemorrhage
2012 Standout
THE DEVELOPMENT AND CLINICAL UTILITY OF THE TAXANE CLASS OF ANTIMICROTUBULE CHEMOTHERAPY AGENTS
1997
New Perspectives on an Old Friend: Optimizing Carboplatin for the Treatment of Solid Tumors
1998
Consolidation Docetaxel After Concurrent Chemoradiotherapy in Stage IIIB Non–Small-Cell Lung Cancer: Phase II Southwest Oncology Group Study S9504
2003
Magnetic Nanoparticles: Design and Characterization, Toxicity and Biocompatibility, Pharmaceutical and Biomedical Applications
2012 Standout
Concurrent Cisplatin, Etoposide, and Chest Radiotherapy in Pathologic Stage IIIB Non–Small-Cell Lung Cancer: A Southwest Oncology Group Phase II Study, SWOG 9019
2002
Seizures and CNS Hemorrhage
2010
Practice parameter: Anticonvulsant prophylaxis in patients with newly diagnosed brain tumors [RETIRED]
2000
Comparative Preclinical and Clinical Pharmacokinetics of a Cremophor-Free, Nanoparticle Albumin-Bound Paclitaxel (ABI-007) and Paclitaxel Formulated in Cremophor (Taxol)
2005
Preservation of Memory With Conformal Avoidance of the Hippocampal Neural Stem-Cell Compartment During Whole-Brain Radiotherapy for Brain Metastases (RTOG 0933): A Phase II Multi-Institutional Trial
2014 Standout
Cyclosporin A Aerosol Improves the Anticancer Effect of Paclitaxel Aerosol in Mice
2004
American Society of Clinical Oncology Treatment of Unresectable Non–Small-Cell Lung Cancer Guideline: Update 2003
2003 Standout
Multimodality imaging of hypoxia in preclinical settings.
2010
Important Flavonoids and Their Role as a Therapeutic Agent
2020 Standout
Works of H. Choy being referenced
A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors
1996
Multiinstitutional phase II trial of paclitaxel, carboplatin, and concurrent radiation therapy for locally advanced non-small-cell lung cancer.
1998
A Phase I Trial of Outpatient Weekly Docetaxel and Concurrent Radiation Therapy for Stage III Unresectable Non–Small-Cell Lung Cancer: A Vanderbuilt Cancer Center Affiliate Network (VCCAN) Trial
2000
Non-small cell lung cancer and central nervous system metastases: Should we be using prophylactic cranial irradiation?
2004
Paclitaxel and concurrent radiation for locally advanced pancreatic and gastric cancer: a phase I study.
1997
Phase I study of weekly outpatient paclitaxel and concurrent cranial irradiation in adults with astrocytomas.
1996
Phase I trial of weekly paclitaxel in advanced lung cancer.
1998
The current state of paclitaxel and radiation in the combined-modality therapy of non-small cell lung cancer
2001
Paclitaxel Disposition in Plasma and Central Nervous Systems of Humans and Rats With Brain Tumors
1995
Phase I trial of outpatient weekly paclitaxel and concurrent radiation therapy for advanced non-small-cell lung cancer.
1994
B3-07: A phase II study of Cetuximab (C225) in combination with chemoradiation
2007
Concurrent Paclitaxel and Radiation Therapy for Solid Tumors
1996
Toxicity Analysis of RTOG 0236 Using Stereotactic Body Radiation Therapy to Treat Medically Inoperable Early Stage Lung Cancer Patients
2007
Concurrent paclitaxel, carboplatin, and radiation therapy for locally advanced non-small cell lung cancer.
1999
Long-term Results of RTOG 0236: A Phase II Trial of Stereotactic Body Radiation Therapy (SBRT) in the Treatment of Patients with Medically Inoperable Stage I Non-Small Cell Lung Cancer
2014
Esophagitis in combined modality therapy for locally advanced non-small cell lung cancer.
1999
A phase II study of cetuximab (C225) in combination with chemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): A report of the 2 year and median survival (MS) for the RTOG 0324 trial
2008
A phase III study of Æ-941 with induction chemotherapy (IC) and concomitant chemoradiotherapy (CRT) for stage III non-small cell Lung cancer (NSCLC) (NCI T99–0046, RTOG 02–70, MDA 99–303): An interim report of toxicity and response
2005
Quality of Life (QOL) Analysis of the Randomized Radiation (RT) Dose-Escalation NSCLC Trial (RTOG 0617): The Rest of the Story
2013
109
2006
Stereotactic Body Radiation Therapy for Medically Inoperable Early-stage Lung Cancer Patients: Analysis of RTOG 0236
2009
PD-039 A phase II study of cetuximab (C225) in combination withchemoradiation (CRT) in patients (PTS) with stage IIIA/B non-small cell lung cancer (NSCLC): An interim overall toxicity report of the RTOG 0324 trial
2005
A phase III study of Æ-941 with induction chemotherapy (IC) and concomitant chemoradiotherapy (CRT) for stage III non- small cell lung cancer (NSCLC) (NCI T99–0046, RTOG 02–70, MDA 99–303)
2007
Paclitaxel plus carboplatin and concurrent radiation therapy for patients with locally advanced non-small cell lung cancer.
1996
Role of paclitaxel in combined modality therapy for locally advanced non-small cell lung cancer (NSCLC): Multiinstitutional trials exploring sequential phase II studies of paclitaxel +/− carboplatin and radiation therapy (+/−hyperfractionation: HFXRT)
2000
Combined modality therapy of NCI-H460 human lung cancer using epidermal growth factor receptor inhibitor, OSI-774, and ionizing radiation in vitro and in vivo
2002
A Phase II Study of Cetuximab (C225) in Combination with Chemoradiation (CRT) in Patients (PTS) with Stage IIIA/B Non-Small Cell Lung Cancer (NSCLC): An Interim Overall Toxicity Report of the RTOG 0324 Trial
2005
Concurrent weekly paclitaxel and radiation therapy for locally advanced non-small cell lung cancer
1997
Prophylactic cranial irradiation in small cell lung cancer: rationale, results, and recommendations.
1997
Patterns of Practice in Radiation Dose Prescription and Treatment Planning for Patients With Lung Cancer Among Members of American Society of Therapeutic Radiology and Oncology
2007
Secondary Endpoints of a Phase II Randomized Trial (RTOG 0212): Impact of Different Total Doses and Schedules of Prophylactic Cranial Irradiation on Chronic Neurotoxicity and Quality of Life for Patients with Limited Disease Small-cell Lung Cancer
2009
Phase III Study of Prophylactic Cranial Irradiation vs. Observation in Patients with Stage III Non–small-cell Lung Cancer: Neurocognitive and Quality of Life Analysis of RTOG 0214
2009